Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$1.8M
+24.0% from 2023
Prescriptions
2,266
$813.41 per claim
Patients
974
666 prescribers
Total spending, 2024
$1.8M
$1,892.39 per patient
Medicare prescription drug plans paid $1.8M for Naproxen Sodium Er in 2024, for 2,266 prescriptions and refills to 974 patients (up 24.0% from 2023). The average cost per claim was $813.41.
New York had the highest Medicare cost for Naproxen Sodium Er in 2024: $1.1M for 1,089 claims, followed by California ($235K).
Venkata L Durbhaka, podiatry in Bronx, NY, had the highest Medicare cost for Naproxen Sodium Er in 2024: 39 claims costing $61K.
Naproxen Sodium Er is made by Teva Pharmaceutical Industries Limited (TEVA), listed in the Medicare spending data as Teva Pharm.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Venkata L Durbhaka Bronx, NY | Podiatry | 39 | 13 | $61K |
| Farhad Kadkhodaei Elyaderani Bronx, NY | Neurology | 34 | 11 | $52K |
| John A Debello |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 66 | 212 | 167 | $196K |
| 2023 | 529 | 2,047 | 738 | $1.5M |
| 2024 | 666 | 2,266 | 974 | $1.8M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Podiatry |
| 33 |
| 13 |
| $48K |
| Mark V Morano Brooklyn, NY | Podiatry | 27 | 11 | $43K |
| Mansukh R Ghadiya Bakersfield, CA | Family Practice | 77 | Under 11 | $42K |
| Avraham Y Henoch New York, NY | Family Practice | 24 | Under 11 | $36K |
| Emil Lavian New York, NY | Podiatry | 24 | Under 11 | $34K |
| Karl Cirincione Brooklyn, NY | Podiatry | 35 | 18 | $33K |
| Boris Khorets Brooklyn, NY | Internal Medicine | 58 | Under 11 | $30K |
| Fausto A Gonzalez South Ozone Park, NY | Internal Medicine | 18 | Under 11 | $25K |
| Melvin B Hurt New York, NY | Podiatry | 15 | Under 11 | $22K |
| Igor Khelemsky Brooklyn, NY | Neurology | 16 | Under 11 | $20K |
| Jeffrey R Rosenblatt Brooklyn, NY | Podiatry | 13 | Under 11 | $20K |
| Olatunde Osofisan Brooklyn, NY | Podiatry | 17 | Under 11 | $20K |
| Rodolfo A Herrera Bedford, TX | Family Practice | 13 | Under 11 | $19K |
| Amit Gandhi Queens Village, NY | Podiatry | 14 | Under 11 | $18K |
| Perry Z Goldenberg Bronx, NY | Podiatry | 11 | Under 11 | $18K |
| Junior R King Brooklyn, NY | Podiatry | 11 | Under 11 | $18K |
| Tamira Vannoy Brooklyn, NY | Podiatry | 14 | Under 11 | $18K |
| Reza S Naghavi Rockville Centre, NY | Internal Medicine | 27 | Under 11 | $17K |
| Carlos F Driggs Bronx, NY | Internal Medicine | 12 | Under 11 | $16K |
| Whitney L Chouteau Irving, TX | Pain Management | 27 | Under 11 | $15K |
| John D Adams Jr. Long Beach, CA | Internal Medicine | 15 | Under 11 | $13K |
| Oleg Karpenko Brooklyn, NY | Podiatry | 27 | Under 11 | $13K |
| Craig P Herman Bronx, NY | Podiatry | 13 | Under 11 | $13K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Teva Pharm TEVA | 2,266 | $1.8M |